JNJ

238.9

+1.85%↑

UNH

271.02

-2.8%↓

TMO

552.32

-3.65%↓

ABT

109.1

+0.24%↑

ISRG

482.13

+1.33%↑

JNJ

238.9

+1.85%↑

UNH

271.02

-2.8%↓

TMO

552.32

-3.65%↓

ABT

109.1

+0.24%↑

ISRG

482.13

+1.33%↑

JNJ

238.9

+1.85%↑

UNH

271.02

-2.8%↓

TMO

552.32

-3.65%↓

ABT

109.1

+0.24%↑

ISRG

482.13

+1.33%↑

JNJ

238.9

+1.85%↑

UNH

271.02

-2.8%↓

TMO

552.32

-3.65%↓

ABT

109.1

+0.24%↑

ISRG

482.13

+1.33%↑

JNJ

238.9

+1.85%↑

UNH

271.02

-2.8%↓

TMO

552.32

-3.65%↓

ABT

109.1

+0.24%↑

ISRG

482.13

+1.33%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

948.05 14.45

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

818

Max

833.84

Schlüsselkennzahlen

By Trading Economics

Einkommen

426M

1.2B

Verkäufe

5.3B

103B

KGV

Branchendurchschnitt

26.453

84.243

Dividendenrendite

0.35

Gewinnspanne

1.173

Angestellte

43,000

EBITDA

212M

1.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+16.31% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.28%

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.3B

105B

Vorheriger Eröffnungskurs

933.6

Vorheriger Schlusskurs

948.05

Nachrichtenstimmung

By Acuity

50%

50%

151 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Feb. 2026, 00:00 UTC

Heiße Aktien

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4. Feb. 2026, 22:55 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4. Feb. 2026, 21:44 UTC

Ergebnisse

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4. Feb. 2026, 21:39 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5. Feb. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5. Feb. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4. Feb. 2026, 23:45 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4. Feb. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4. Feb. 2026, 22:59 UTC

Akquisitionen, Fusionen, Übernahmen

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4. Feb. 2026, 22:30 UTC

Ergebnisse

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4. Feb. 2026, 22:30 UTC

Ergebnisse

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4. Feb. 2026, 22:21 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4. Feb. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4. Feb. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4. Feb. 2026, 21:53 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4. Feb. 2026, 21:51 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Feb. 2026, 21:45 UTC

Ergebnisse

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4. Feb. 2026, 21:44 UTC

Ergebnisse

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4. Feb. 2026, 21:43 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4. Feb. 2026, 21:41 UTC

Ergebnisse

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4. Feb. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

16.31% Vorteil

12-Monats-Prognose

Durchschnitt 956.09 USD  16.31%

Hoch 1,012 USD

Tief 880 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

151 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat